Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome.
B Lachmann - The European Respiratory journal. Supplement, 1989 - europepmc.org
This brief review describes the pathogenesis of the adult respiratory distress syndrome
(ARDS) and the rationale for surfactant replacement therapy. In four animal models in which …
(ARDS) and the rationale for surfactant replacement therapy. In four animal models in which …
Inactivation of pulmonary surfactant and the treatment of acute lung injuries
H William Taeusch, Kevin MW … - Pediatric Pathology & …, 2001 - Taylor & Francis
Inactivation of pulmonary surfactant may be important in acute lung injury and acute
respiratory distress syndrome. Treatment of surfactant dysfunction by instilling exogenous …
respiratory distress syndrome. Treatment of surfactant dysfunction by instilling exogenous …
Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
JW Logan, FR Moya - Therapeutics and Clinical Risk Management, 2009 - Taylor & Francis
Introduction: Available literature suggests that the advantage of animal-derived surfactants
over first-generation synthetic agents derives from the presence of surface-active proteins …
over first-generation synthetic agents derives from the presence of surface-active proteins …
Surfactant biology and clinical application
SE Poynter, AM LeVine - Critical care clinics, 2003 - criticalcare.theclinics.com
Pulmonary surfactant is a highly surface-active material that lines the alveolar surface of the
lung. The major function of pulmonary surfactant is the reduction of surface tension at the air …
lung. The major function of pulmonary surfactant is the reduction of surface tension at the air …
Expanded uses of surfactant therapy
TE Wiswell - Clinics in perinatology, 2001 - perinatology.theclinics.com
Pulmonary surfactant is a complex and highly surface-active material necessary for
sustaining life by lowering surface tension to assist alveolar expansion, allowing gas …
sustaining life by lowering surface tension to assist alveolar expansion, allowing gas …
The use of surfactant in children with acute respiratory distress syndrome: efficacy in terms of oxygenation, ventilation and mortality
H Yapıcıoğlu, D Yıldızdaş, İ Bayram, Y Sertdemir… - Pulmonary …, 2003 - Elsevier
Purpose. The aim of this prospectively designed study was to investigate the efficacy of
surfactant (S) for acute respiratory distress syndrome (ARDS) in children. Materials and …
surfactant (S) for acute respiratory distress syndrome (ARDS) in children. Materials and …
Surfactant replacement therapy in preterm infants: a European survey
AH Van Kaam, AP De Jaegere, D Borensztajn… - Neonatology, 2011 - karger.com
Background: Exogenous surfactant is an undisputed treatment for neonatal respiratory
distress syndrome but its efficacy is highly dependent on the treatment strategy. International …
distress syndrome but its efficacy is highly dependent on the treatment strategy. International …
Overview of surfactant replacement trials
Clinical trials have evaluated the overall efficacy of surfactant therapy, as well as the relative
efficacy of different surfactant preparations, the optimal timing of administration and the …
efficacy of different surfactant preparations, the optimal timing of administration and the …
Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?
S Sinha, F Moya, SM Donn - Current opinion in pediatrics, 2007 - journals.lww.com
Surfactant for respiratory distress syndrome: are there impo... : Current Opinion in Pediatrics
Surfactant for respiratory distress syndrome: are there important clinical differences among …
Surfactant for respiratory distress syndrome: are there important clinical differences among …